Nextgen rbis operations and maintenance

Active Awarded Last action

Contract number
75F40123F19003
Awardee
Awarding agency
Obligated
$3,736,939

Award facts

Contract value 100% obligated
$3,736,938.97 Current and potential, with all options
Completion date 83% complete
Current and potential, with all options
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Calverton, MD 20705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Nextgen rbis operations and maintenance - the purpose of this modification is to DE-obligate funds, cancel non-funded item 3, and close out the contract. -$10,857
Original award $3,747,796

About this award

Booz Allen Hamilton Inc. has been awarded a modification to its NextGen Reduced Business Information System (RBIS) Operations and Maintenance contract with the Food and Drug Administration, with a ceiling value of $3.74 million and an ultimate completion date of July 31, 2027. This contract, awarded as a Blanket Purchase Agreement call under the General Services Administration's Multiple Award Schedule, represents a firm fixed-price engagement for operations and maintenance services supporting the FDA's RBIS platform. The modification serves to de-obligate funds, cancel non-funded item 3, and close out the contract, reflecting contract administration activities associated with the original award issued on March 23, 2023.

As a large business prime contractor, Booz Allen Hamilton brings extensive experience supporting FDA missions related to regulatory science optimization, electronic submissions, and enterprise information technology infrastructure. The contract performs work at the Calverton, Maryland location and aligns with the company's substantial portfolio of FDA task orders spanning hundreds of millions in aggregate value across multiple vehicle types. This engagement reflects the FDA's reliance on experienced systems integrators to maintain critical IT infrastructure supporting the agency's regulatory operations and data management requirements.

Quick answers

Who was awarded contract 75F40123F19003?

75F40123F19003 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on March 23, 2023.

How much is contract 75F40123F19003 worth?

The government has obligated $3,736,939 on 75F40123F19003.

Is contract 75F40123F19003 an order under another contract?

Yes. 75F40123F19003 is a BPA call under GS35F386DA-75F40122A00013, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40123F19003 competed?

The extent of competition for 75F40123F19003 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award